The latest Pharmaceutical and Healthcare disease pipeline guide Parkinson ’s disease Pipeline market Review, H2 2017, provides an overview of the Parkinson’s Disease (Central Nervous System) pipeline landscape.
- Advertising -
Parkinson’s disease is a neurodegenerative disorder characterized by movement dysfunctions. It causes involuntary shaking, stiffness and impaired locomotory functions.
Age, genetic factors, head trauma, environmental factors, hormonal changes, etc are predisposing factors for Parkinson’s Disease Pipeline Market. Parkinson’s disease results in abnormal functioning or death of neurons.
- Advertising -
The neurons are responsible for the synthesis of neurotransmitter dopamine which is further responsible for the transmission of signals. The effect on the neurons blocks effective neurotransmission and may lead to eventual decline in movement and coordination.
Get this Research Report at www.reportsnreports.com/contacts/d…aspx?name=1264084
Pharmaceutical and Healthcare latest pipeline guide Parkinson’s Disease - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Parkinson’s Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Parkinson’s Disease Pipeline Market (Central Nervous System) guide also reviews of key players involved in therapeutic development for Parkinson’s Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 2, 8, 41, 42, 4, 190, 50 and 7 respectively.
Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 46 and 13 molecules, respectively.
Direct Access at www.reportsnreports.com/purchase.aspx?name=1264084
Parkinson’s Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For More Details Inquire at www.reportsnreports.com/contacts/i…aspx?name=1264084
- The pipeline guide provides a snapshot of the global therapeutic landscape of Parkinson’s Disease (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Parkinson ’s disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Parkinsons Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Parkinsons Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Parkinsons Disease (Central Nervous System)
Table of Contents
Parkinsons Disease - Overview
Parkinsons Disease - Therapeutics Development
Parkinsons Disease - Therapeutics Assessment
Parkinsons Disease - Companies Involved in Therapeutics Development
Parkinsons Disease - Drug Profiles
Parkinsons Disease - Dormant Projects
Parkinsons Disease - Discontinued Products
Parkinsons Disease - Product Development Milestones
List of Tables.